EE200000388A - Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet - Google Patents

Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet

Info

Publication number
EE200000388A
EE200000388A EEP200000388A EEP200000388A EE200000388A EE 200000388 A EE200000388 A EE 200000388A EE P200000388 A EEP200000388 A EE P200000388A EE P200000388 A EEP200000388 A EE P200000388A EE 200000388 A EE200000388 A EE 200000388A
Authority
EE
Estonia
Prior art keywords
surfactant
pharmaceutical composition
composition containing
lipophilic glucocorticosteroid
micelles
Prior art date
Application number
EEP200000388A
Other languages
English (en)
Inventor
Sj�quist Gabrielle
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of EE200000388A publication Critical patent/EE200000388A/et

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Dispersion Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EEP200000388A 1997-12-22 1998-12-22 Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet EE200000388A (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE9704833A SE9704833D0 (sv) 1997-12-22 1997-12-22 New formulation
PCT/SE1998/002426 WO1999032089A1 (en) 1997-12-22 1998-12-22 Pharmaceutical compositions comprising micelles comprising lipophilic glucocorticosteroid and only one surfactant

Publications (1)

Publication Number Publication Date
EE200000388A true EE200000388A (et) 2002-02-15

Family

ID=20409536

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200000388A EE200000388A (et) 1997-12-22 1998-12-22 Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet

Country Status (20)

Country Link
EP (1) EP1043973A1 (et)
JP (1) JP2001526210A (et)
KR (1) KR20010024789A (et)
CN (1) CN1283106A (et)
AR (1) AR017220A1 (et)
AU (1) AU1993599A (et)
BR (1) BR9813811A (et)
CA (1) CA2315782A1 (et)
EE (1) EE200000388A (et)
HU (1) HUP0102365A3 (et)
ID (1) ID26945A (et)
IL (1) IL136880A0 (et)
NO (1) NO20003220L (et)
NZ (1) NZ505073A (et)
PL (1) PL341361A1 (et)
SE (1) SE9704833D0 (et)
SK (1) SK9532000A3 (et)
TR (1) TR200001977T2 (et)
WO (1) WO1999032089A1 (et)
ZA (1) ZA9811461B (et)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9902674D0 (sv) * 1999-07-12 1999-07-12 Astra Ab New composition
SE0000332D0 (sv) * 2000-01-31 2000-01-31 Astrazeneca Ab New use
US6759398B2 (en) 2000-08-05 2004-07-06 Smithkline Beecham Corporation Anti-inflammatory androstane derivative
US6777399B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858593B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6858596B2 (en) 2000-08-05 2005-02-22 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivative
US6777400B2 (en) 2000-08-05 2004-08-17 Smithkline Beecham Corporation Anti-inflammatory androstane derivative compositions
US6787532B2 (en) * 2000-08-05 2004-09-07 Smithkline Beecham Corporation Formulation containing anti-inflammatory androstane derivatives
GB0019172D0 (en) 2000-08-05 2000-09-27 Glaxo Group Ltd Novel compounds
US6750210B2 (en) 2000-08-05 2004-06-15 Smithkline Beecham Corporation Formulation containing novel anti-inflammatory androstane derivative
SE0100901D0 (sv) * 2001-03-15 2001-03-15 Astrazeneca Ab New composition
UA77656C2 (en) 2001-04-07 2007-01-15 Glaxo Group Ltd S-fluoromethyl ester of 6-alpha, 9-alpha-difluoro-17-alpha-[(2-furanylcarbonyl)oxy]-11-beta-hydroxy-16- alpha-methyl-3-oxoandrosta-1,4-dien-17-beta-carbothioacid as anti-inflammatory agent
GB2389530B (en) 2002-06-14 2007-01-10 Cipla Ltd Pharmaceutical compositions
CA2536283A1 (en) * 2003-08-20 2005-03-03 Ajinomoto Co., Inc. Pharmaceutical preparations having an improved solubility
US8497258B2 (en) 2005-11-12 2013-07-30 The Regents Of The University Of California Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract
CN100579510C (zh) * 2006-04-13 2010-01-13 新疆维吾尔自治区包虫病临床研究所 新型前体胶束制剂及其生产方法
US20090143343A1 (en) 2007-11-13 2009-06-04 Meritage Pharma, Inc. Compositions for the treatment of inflammation of the gastrointestinal tract
CA2705681C (en) 2007-11-13 2013-06-18 Meritage Pharma, Inc. Corticosteroid compositions
US8795634B2 (en) * 2008-09-12 2014-08-05 Critical Pharmaceuticals Limited Absorption of therapeutic agents across mucosal membranes or the skin
CN101982168B (zh) * 2010-11-02 2012-05-23 山东大学 一种槲皮素纳米胶束制剂及其制备方法
CN102793678B (zh) * 2011-05-26 2017-06-30 邓世明 一种不含吐温的多烯紫杉醇注射剂的制备方法
DE102011108948A1 (de) * 2011-07-29 2013-01-31 Achim Göpferich Wässrige, kolloidale Lösungen von lipophilen Substanzen,insbesondere Arzneistofflösungen
JP5456802B2 (ja) * 2012-01-23 2014-04-02 株式会社Ｃａｃ 細胞遊走促進剤及び創傷治療用の経皮吸収剤
AU2014291615B2 (en) * 2013-07-17 2019-09-26 Council Of Scientific & Industrial Research Pharmaceutical composition for the treatment of diminution of bone tissue
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
AU2017239645A1 (en) 2016-04-01 2018-10-18 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
KR102086316B1 (ko) * 2019-09-09 2020-03-09 한국콜마주식회사 경피흡수성이 우수한 화장료 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0179583A1 (en) * 1984-10-04 1986-04-30 Merck & Co. Inc. A system for enhancing the water dissolution rate and solubility of poorly soluble drugs
US4994439A (en) * 1989-01-19 1991-02-19 California Biotechnology Inc. Transmembrane formulations for drug administration
SA95160463B1 (ar) * 1994-12-22 2005-10-04 استرا أكتيبولاج مساحيق للاستنشاق

Also Published As

Publication number Publication date
HUP0102365A3 (en) 2002-01-28
NZ505073A (en) 2002-09-27
HUP0102365A2 (hu) 2001-11-28
PL341361A1 (en) 2001-04-09
CA2315782A1 (en) 1999-07-01
KR20010024789A (ko) 2001-03-26
BR9813811A (pt) 2000-10-03
ZA9811461B (en) 1999-06-22
CN1283106A (zh) 2001-02-07
EP1043973A1 (en) 2000-10-18
AU1993599A (en) 1999-07-12
NO20003220D0 (no) 2000-06-21
TR200001977T2 (tr) 2000-12-21
NO20003220L (no) 2000-08-22
JP2001526210A (ja) 2001-12-18
WO1999032089A1 (en) 1999-07-01
AR017220A1 (es) 2001-08-22
SE9704833D0 (sv) 1997-12-22
SK9532000A3 (en) 2000-11-07
IL136880A0 (en) 2001-06-14
ID26945A (id) 2001-02-22

Similar Documents

Publication Publication Date Title
EE200000388A (et) Ravimkoostis, mis sisaldab mitselle, mis sisaldavad lipofiilset glükokortikosteroidi ja ainult üht pindaktiivset ainet
ID24654A (id) Formulasi farmasi omeprazola
BR9810116B1 (pt) composição de solução e processo para sua preparação.
EE201000020A (et) Ravimkompositsioonid, mis p?hinevad antikolinergiliselt toimivatel henditel ja
DZ2685A1 (fr) Formulation pharmaceutique orale à libération prolongée.
EE200000232A (et) Farmatseutiline kompositsioon ja selle kasutamine
DE69726015D1 (de) Pharmazeutische zusammensetzung enthaltend koenzym q-10
EE200000225A (et) Arüüloksüalküüldialküülamiinid, nende valmistamismeetodid ja farmatseutiline kompositsioon
FI973828A0 (fi) Yhdisteitä ja koostumuksia aktiivisten aineiden annostelemiseksi
KR960702303A (ko) 항억제제 제형 (Antidepressant Dosage Form)
FI973475A (fi) Koostumus ja sitä sisältävä tuote
BR9808422B1 (pt) composto, composiÇço farmacÊutica, uso de um composto, e, processo para a preparaÇço de um composto.
BR9607851B1 (pt) combinaÇço e formulaÇço farmacÊutica.
DE69840097D1 (de) Körnige waschmittelzusammensetzungen und deren herstellung
EE200000226A (et) 3,6-poolketaalid 9a-asaliidide klassist, nende valmistamismeetod ja farmatseutiline kompositsioon
DE69820919D1 (de) Mit Wasser quellbare Zusammensetzungen und Dichtungsmassen
BR9816030B1 (pt) composiÇço detergente sàlida e seu uso.
ATE295150T1 (de) Pharmazeutische zusammensetzungen
DE69813287D1 (de) Lipidzusammensetzungen und deren verwendung
MA26531A1 (fr) Composition pharmaceutique
FR2767062B1 (fr) Composition comprenant de la propolis
EE04260B1 (et) Farmatseutiline kompositsioon, selle valmistamisemeetod ja kasutamine
EE03387B1 (et) Kombineeritud ravimpreparaat, selle kasutamine ja meetod selle valmistamiseks
DE69512715D1 (de) Aconitin ähnliche verbindung und antipyretisches, analgetisches und entzündungshemmendes mittel
ITFI940009A0 (it) Antagonisti delle tachichinine, loro preparazione e formulazioni farmaceutiche che li contengono.